SonoScape Medical

SonoScape Medical EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of SonoScape Medical (300633.SZ) as of Nov 20, 2026 is -238.78. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 31.92 — a change of -848.08% (lower).

EV/OCF

-238.78

YoY

-848.08%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of SonoScape Medical is 2025 -238.78 . EV/OCF (Enterprise Value to Operating Cash Flow) of SonoScape Medical was 2024 31.92 . It decreases by -848.08% lower compared to the previous year.

The SonoScape Medical EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
49.21 CNY
Jan 1, 2019
58.11 CNY
Jan 1, 2020
40.60 CNY
Jan 1, 2021
33.52 CNY
Jan 1, 2022
20.96 CNY
Jan 1, 2023
19.62 CNY
Jan 1, 2024
31.92 CNY
Jan 1, 2025
-238.78 CNY
The SonoScape Medical EV/OCF history
YEAREV/OCFYoY
-238.78-848.08%
31.92+62.67%
19.62-6.40%
20.96-37.45%
33.52-17.44%
40.60-30.14%
58.11+18.08%
49.21-41.27%
83.78+1.78%
82.32-59.45%
202.97+101.70%
100.63—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SonoScape Medical Stock analysis

What does SonoScape Medical do? SonoScape Medical Corp is a company based in Shenzhen, China, operating within the Health Care sector. It focuses on the research and development, production, and sales of medical diagnostic equipment. The company has a workforce of 2,334 employees. SonoScape Medical Corp completed its initial public offering (IPO) on April 6, 2017. Its primary products include medical ultrasound diagnostic equipment, such as color Doppler ultrasound systems and B-type ultrasound devices, as well as medical electronic endoscopes and related consumables, and blood analyzers. The company's headquarters are located in Shenzhen, Guangdong, and it maintains a corporate website at https://www.sonoscape.com/. SonoScape Medical Corp operates in the health care industry, providing diagnostic tools used in medical settings for patient assessment and treatment planning. The company's product portfolio emphasizes ultrasound technology, endoscopy, and laboratory equipment for blood analysis. It serves healthcare providers and facilities globally, though specific market details are not provided. The company's operations are centered around the development and commercialization of diagnostic solutions for the medical field. SonoScape Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SonoScape Medical stock

EV/OCF (Enterprise Value to Operating Cash Flow) of SonoScape Medical is -238.78 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of SonoScape Medical changed from 31.92 to -238.78, representing a -848.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) SonoScape Medical since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s SonoScape Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — SonoScape Medical

All Key Metrics — SonoScape Medical